Grants per year
Personal profile
Education/Academic qualification
Medicine, MD, Aleppo University Medical School
… → 1985
Fingerprint
Dive into the research topics where Jamile Shammo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
Prot #PTG-300-11: A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera
Shammo, J. (PD/PI)
Medpace Clinical Research LLC, Protagonist Therapeutics, Inc.
11/20/23 → 11/20/26
Project: Research project
-
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
Dingli, D., De Castro, C., Koprivnikar, J., Kulasekararaj, A., Maciejewski, J., Mulherin, B., Panse, J., Pullarkat, V., Röth, A., Shammo, J., Terriou, L., Weitz, I., Yermilov, I., Gibbs, S., Broder, M., Beenhouwer, D. & Kuter, D., 2024, In: Hematology (United Kingdom). 29, 1, 2329030.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape
Waheed, A., Shammo, J. & Dingli, D., Mar 2024, In: Blood Reviews. 64, 101158.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
ALXN2040-PNH-301 Investigators, Dec 2023, In: The Lancet Haematology. 10, 12, p. e955-e965Research output: Contribution to journal › Article › peer-review
24 Scopus citations -
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
ACTIV-4C Study Group, Apr 2023, In: Annals of internal medicine. 176, 4, p. 515-523 9 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Rippel, N., Tremblay, D., Zubizarreta, N., Podoltsev, N., Gotlib, J., Heaney, M., Kuykendall, A., O'Connell, C., Shammo, J. M., Fleischman, A., Kremyanskaya, M., Hoffman, R., Mesa, R., Yacoub, A. & Mascarenhas, J., Aug 2022, In: Leukemia Research. 119, 106903.Research output: Contribution to journal › Article › peer-review
Datasets
-
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
Dingli, D. (Creator), De Castro III, C. (Contributor), Koprivnikar, J. (Creator), Kulasekararaj, A. (Creator), Maciejewski, J. (Creator), Mulherin, B. (Creator), Panse, J. (Creator), Pullarkat, V. (Creator), Röth, A. (Creator), Shammo, J. (Creator), Terriou, L. (Creator), Weitz, I. (Creator), Yermilov, I. (Creator), Gibbs, S. (Creator), Broder, M. (Creator), Beenhouwer, D. (Creator) & Kuter, D. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25450653.v1, https://tandf.figshare.com/articles/dataset/Expert_consensus_on_the_management_of_pharmacodynamic_breakthrough-hemolysis_in_treated_paroxysmal_nocturnal_hemoglobinuria/25450653/1
Dataset